IGC Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.

About IGC

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. 

CEO
Ram Mukunda
CEORam Mukunda
Employees
67
Employees67
Headquarters
Potomac, Maryland
HeadquartersPotomac, Maryland
Founded
2005
Founded2005
Employees
67
Employees67

IGC Key Statistics

Market cap
24.25M
Market cap24.25M
Price-Earnings ratio
-2.45
Price-Earnings ratio-2.45
Dividend yield
Dividend yield
Average volume
174.16K
Average volume174.16K
High today
$0.3099
High today$0.3099
Low today
$0.2922
Low today$0.2922
Open price
$0.2925
Open price$0.2925
Volume
248.83K
Volume248.83K
52 Week high
$0.62
52 Week high$0.62
52 Week low
$0.2525
52 Week low$0.2525

People also own

Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.